BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8924401)

  • 41. Evaluation of the scintigraphic technique for detecting bone metastases in 100 breast cancer patients.
    Molino A; Benini F; Giorgetti PG; Capelli MC; Zamboni M; Savarin T; Bassetto A; Vettore L; Marabini A
    Tumori; 1979 Aug; 65(4):473-9. PubMed ID: 494400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A case report of multiple bone metastases of breast carcinoma effectively treated with mild chemo-endocrine therapy].
    Shibata M; Saito A; Hareyama M; Morita K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):245-8. PubMed ID: 1736837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer.
    Baker RR; Holmes ER; Alderson PO; Khouri NF; Wagner HN
    Ann Surg; 1977 Sep; 186(3):363-8. PubMed ID: 889378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How far investigations for occult metastases in breast cancer aid the clinician.
    Glynne-Jones R; Young T; Ahmed A; Ell PJ; Berry RJ
    Clin Oncol (R Coll Radiol); 1991 Mar; 3(2):65-72. PubMed ID: 2031885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The value of follow-up bone scans in the management of postoperative breast cancer--when should it be performed?].
    Suzuki T; Watarai J; Ohgushi M; Adachi M; Yamaguchi K
    Gan No Rinsho; 1987 Sep; 33(11):1314-7. PubMed ID: 3669318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Panhypopituitarism as a consequence of metastase of breast cancer in sella turcica.
    Ruiz Hernández G; Chesa-Jiménez J; San Martín Ciges E; Castillo Pallarés FJ; de Avila CR
    Nuklearmedizin; 1996 Aug; 35(4):143-5. PubMed ID: 8784867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of preoperative radionuclide bone scan in suspected primary breast carcinoma.
    O'Connell MJ; Wahner HW; Ahmann DL; Edis AJ; Silvers A
    Mayo Clin Proc; 1978 Apr; 53(4):221-6. PubMed ID: 633949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The development of skeletal metastases.
    Galasko CS
    Nihon Seikeigeka Gakkai Zasshi; 1989 May; 63(5):667-76. PubMed ID: 2794640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between bone scan findings and collagenase activities in patients with breast cancer.
    Kim CG; Kim EE; Kim HJ; Choe JG; Hong SC; Wong FC; Theriault RL; Nicolson GL; Podoloff DA
    Invest Radiol; 1997 May; 32(5):302-5. PubMed ID: 9140751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of the pelvic radiograph alone to assess therapeutic response in bone metastases from breast cancer.
    Twining P; Williams MR; Morris AH; Blamey RW
    Clin Radiol; 1988 Nov; 39(6):583-5. PubMed ID: 3243049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast cancer with bone-only metastases. Visceral metastases-free rate in relation to anatomic distribution of bone metastases.
    Yamashita K; Ueda T; Komatsubara Y; Koyama H; Inaji H; Yonenobu K; Ono K
    Cancer; 1991 Aug; 68(3):634-7. PubMed ID: 2065284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simulated bone metastases: a case study of two patients with breast cancer: comment.
    Rodger A
    Australas Radiol; 2000 Feb; 44(1):130. PubMed ID: 10761277
    [No Abstract]   [Full Text] [Related]  

  • 53. Conventional radiograms for assessment of salm-calcitonin therapy for bone metastases from breast carcinoma.
    Geyer J; Quadt C; Perlick E; Starke K; Stier G; Tanneberger S
    Eur J Radiol; 1991; 12(2):124-6. PubMed ID: 2036999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone scan had no role in the staging of 765 consecutive operable T(1-2)N(0-1) breast cancer patients without skeletal symptoms.
    Curigliano G; Ferretti G; Colleoni M; Marrocco E; Peruzzotti G; De Cicco C; Paganelli G; Goldhirsch A
    Ann Oncol; 2001 May; 12(5):724-5. PubMed ID: 11432637
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of new sclerotic bone metastases in breast cancer patients during treatment.
    Ciray I; Aström G; Andréasson I; Edekling T; Hansen J; Bergh J; Ahlström H
    Acta Radiol; 2000 Mar; 41(2):178-82. PubMed ID: 10741794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pattern of metastases in Nigerian breast cancer patients.
    Ketiku KK
    Clin Radiol; 1986 Nov; 37(6):563-5. PubMed ID: 3791853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of chest and skeletal survey to assess the time of relapse in breast cancer.
    Tesoro-Tess JD; Valagussa P; Gardani G; Rossi A; Tancini G; Bajetta E; Marchini S; Uslenghi C
    Tumori; 1981 Feb; 67(1):35-8. PubMed ID: 7245352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic Value of Plain Radiography for Symptomatic Bone Metastasis at the First Visit.
    Kitagawa Y; Yamaoka T; Yokouchi M; Ito T; Mizuno Y; Sudo Y; Kim Y; Tsunoda R; Takai S
    J Nippon Med Sch; 2018; 85(6):315-321. PubMed ID: 30568057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and radiographic correlations in breast cancer patients with osseous metastases.
    Barry WF; Wells SA; Cox CE; Haagensen DE
    Skeletal Radiol; 1981; 6(1):27-32. PubMed ID: 7466413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metastatic Hip Tumor in a Middle-Aged Woman.
    Callan B
    J Orthop Sports Phys Ther; 2016 May; 46(5):400. PubMed ID: 27133943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.